- Report
- August 2025
- 189 Pages
Global
From €3490EUR$3,939USD£3,019GBP
- Report
- August 2025
- 197 Pages
Global
From €3141EUR$3,545USD£2,717GBP
€3490EUR$3,939USD£3,019GBP
- Report
- March 2025
- 142 Pages
Global
From €2657EUR$2,999USD£2,299GBP
- Report
- August 2025
- 246 Pages
Global
From €5183EUR$5,850USD£4,484GBP
Ulipristal Acetate (UPA) is a medication used in the field of Sexual and Reproductive Health (SRH). It is a selective progesterone receptor modulator (SPRM) used for emergency contraception and for the treatment of uterine fibroids. UPA is a safe and effective option for women seeking emergency contraception, as it is more effective than other methods and can be taken up to five days after unprotected intercourse. It is also used to treat symptomatic uterine fibroids, as it can reduce the size of the fibroids and reduce associated symptoms.
UPA is available in many countries, including the United States, Canada, and the European Union. It is available in both generic and branded forms, and is typically sold as a single-dose tablet.
Some companies in the UPA market include HRA Pharma, Teva Pharmaceuticals, and Mylan. Show Less Read more